A Phase 2 Single-Masked, Randomized Study of Latanoprost PPDS in Ocular Hypertension or Open-Angle Glaucoma
Public ClinicalTrials.gov record NCT02014142. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2 Single-Masked, Randomized Study of the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle Glaucoma
Study identification
- NCT ID
- NCT02014142
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Mati Therapeutics Inc.
- Industry
- Enrollment
- 86 participants
Conditions and interventions
Conditions
Interventions
- Latanoprost Punctal Plug Delivery System (L-PPDS) Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2013
- Primary completion
- Nov 30, 2016
- Completion
- Nov 30, 2016
- Last update posted
- Jan 17, 2017
2013 – 2016
United States locations
- U.S. sites
- 18
- U.S. states
- 12
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arizona Eye Center | Chandler | Arizona | 85225 | — |
| Arizona Glaucoma Specialists | Phoenix | Arizona | 85050 | — |
| Wolstan & Goldberg Eye Associates | Torrance | California | 90505 | — |
| Argus Research at Cape Coral Eye Center | Cape Coral | Florida | 33904 | — |
| Eye Associates of Fort Myers | Fort Myers | Florida | 33901 | — |
| Indiana Universtiy - Eugene and Marilyn Glick Eye Institute Ophthalmology Center | Indianapolis | Indiana | 46202 | — |
| Cincinnati Eye Institute | Edgewood | Kentucky | 41017 | — |
| Great Lakes Eye Care | Saint Joseph | Michigan | 49085 | — |
| Chu Vision Institute | Bloomington | Minnesota | 55420 | — |
| Ophthalmology Associates | St Louis | Missouri | 63131 | — |
| Comprehensive Eye Care, Ltd. | Washington | Missouri | 63090 | — |
| Abrams Eye Institute | Las Vegas | Nevada | 89148 | — |
| Ophthalmic Consultants of Long Island | Lynbrook | New York | 11563 | — |
| Dr. Steven T. Simmons | Slingerlands | New York | 12159 | — |
| Philadelphia Eye Associates | Philadelphia | Pennsylvania | 19148 | — |
| Wills Eye Hospital | Phildelphia | Pennsylvania | 19107 | — |
| University Eye Surgeons | Maryville | Tennessee | 37803 | — |
| Total Eye Care | Memphis | Tennessee | 38119 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02014142, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 17, 2017 · Synced Jun 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02014142 live on ClinicalTrials.gov.